Trademark: 77950302
Word
CCH
Status
Dead
Status Code
710
Status Date
Friday, September 24, 2021
Serial Number
77950302
Registration Number
3922019
Registration Date
Tuesday, February 22, 2011
Mark Type
3000
Filing Date
Thursday, March 4, 2010
Published for Opposition
Tuesday, December 7, 2010
Cancellation Date
Friday, September 24, 2021

Trademark Owner History
TiGenix NV - Original Registrant

Classifications
1 [ pharmaceutical, veterinary or medicinal preparations for quality control of human cartilage cells in vivo; reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for use in monitoring the expansion and implanting of human cartilage cells in vivo for scientific purposes ]
5 [ pharmaceutical, veterinary or medicinal preparations for the expansion and implanting of human cartilage cells in vivo; cultures and nutritional substrates for the expansion and implanting of human cartilage cells in vivo; medical in vitro diagnostic tests, namely, test strips, immunological assays and immunological products, namely, enzyme based assay systems for detection of markers of disease, for use in monitoring the expansion and implanting of human cartilage cells in vivo; hormones and substances designed for stimulating cell growth, namely, cell growth media for growing cells for medical or clinical purposes; enzymes for medical purposes; antibodies for medical purposes for the expansion of human cartilage cells in vivo ]
10 surgical apparatus and instruments for medical or veterinary use, also in the form of kits comprising medical needles, medical syringes and biopsy instruments for expansion and implanting of human cartilage cells in vivo; biopsy kits comprising medical needles and medical syringes for harvesting, expansion and implanting of human cartilage cells in vivo, and containers for use as receptacles for harvested human cartilage cells; kits comprising medical needles, medical syringes and biopsy instruments for expansion and implanting of human cartilage cells in vivo
42 [ pharmaceutical research services for the expansion and implanting of human cartilage cells in vivo; pharmaceutical drug development services for the expansion and implanting of human cartilage cells in vivo; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing and diagnostics for the expansion and implanting of human cartilage cells in vivo ]
44 pharmaceutical advice; dispensing of pharmaceuticals; pharmaceutical consultation; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals in the field of expansion and implanting of human cartilage cells; veterinary and medical services; implantation of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants; medical follow-up services in the field of diagnostic testing, and monitoring and reporting the expansion and implanting of human cartilage cells in vivo; medical follow-up services; medical testing, namely, carrying out of testing of expanded or implanted human cartilage cells for medical purposes; medical diagnostic testing and monitoring of the expansion and implanting of human cartilage cells in vivo
Color is not claimed as a feature of the mark.
The mark consists of the letters "CCH", bisected by a line beginning at the far right side of the cross bar of the letter "H", and extending left to the center of the first letter "C", where it ends in a dot at the center of this letter.

Trademark Events
Sep 24, 2021
Cancelled Sec. 8 (10-Yr)/Expired Section 9
Feb 22, 2020
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
Mar 27, 2017
Notice Of Acceptance Of Sec. 8 - E-Mailed
Mar 27, 2017
Registered - Partial Sec. 8 (6-Yr) Accepted
Mar 25, 2017
Case Assigned To Post Registration Paralegal
Feb 16, 2017
Teas Section 8 Received
Feb 22, 2011
Registered-Principal Register
Dec 7, 2010
Official Gazette Publication Confirmation E-Mailed
Dec 7, 2010
Published For Opposition
Nov 4, 2010
Law Office Publication Review Completed
Nov 4, 2010
Approved For Pub - Principal Register
Nov 4, 2010
Examiner's Amendment Entered
Nov 4, 2010
Notification Of Examiners Amendment E-Mailed
Nov 4, 2010
Examiners Amendment E-Mailed
Nov 4, 2010
Examiners Amendment -Written
Oct 14, 2010
Previous Allowance Count Withdrawn
Sep 24, 2010
Withdrawn From Pub - Og Review Query
Sep 13, 2010
Law Office Publication Review Completed
Sep 11, 2010
Approved For Pub - Principal Register
Sep 10, 2010
Teas/Email Correspondence Entered
Sep 10, 2010
Correspondence Received In Law Office
Sep 10, 2010
Assigned To Lie
Aug 23, 2010
Teas Response To Office Action Received
Jun 13, 2010
Notification Of Non-Final Action E-Mailed
Jun 13, 2010
Non-Final Action E-Mailed
Jun 13, 2010
Non-Final Action Written
Jun 7, 2010
Assigned To Examiner
Mar 10, 2010
Notice Of Design Search Code Mailed
Mar 9, 2010
New Application Office Supplied Data Entered In Tram
Mar 8, 2010
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24